Aveanna Healthcare Holdings Inc. (AVAH)
NASDAQ: AVAH · Real-Time Price · USD
8.59
-0.27 (-3.05%)
At close: Jan 9, 2026, 4:00 PM EST
8.50
-0.09 (-1.05%)
After-hours: Jan 9, 2026, 6:07 PM EST
AVAH Market Cap
AVAH has a market cap or net worth of $1.79 billion as of January 9, 2026. Its market cap has increased by 107.31% in one year.
Market Cap
1.79B
Enterprise Value
3.15B
1-Year Change
107.31%
Ranking
Category
Stock Price
$8.59
Market Cap Chart
Since the IPO on April 29, 2021, AVAH's market cap has decreased from $2.16B to $1.79B, a decrease of -16.99%. That is a compound annual growth rate of -3.88%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Jan 9, 2026 | 1.79B | 5.14% |
| Dec 31, 2025 | 1.71B | 93.29% |
| Dec 31, 2024 | 883.04M | 72.75% |
| Dec 29, 2023 | 511.16M | 252.49% |
| Dec 30, 2022 | 145.02M | -89.36% |
| Dec 31, 2021 | 1.36B | -36.96% |
| Apr 29, 2021 | 2.16B | - |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Eli Lilly and Company | 992.16B |
| Johnson & Johnson | 499.90B |
| AbbVie | 412.54B |
| UnitedHealth Group | 309.53B |
| AstraZeneca | 297.23B |
| Novartis AG | 273.49B |
| Merck & Co. | 269.55B |
| Novo Nordisk | 254.60B |